Schrodinger, Inc.

SDGR Healthcare Health Information Services

Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024. In the quarter to June 2026, revenue grew 7.54%, EPS grew 113.6% and free cash flow grew 34.4%, each against the same quarter a year earlier.

22.60 2.88 −11.30%
Market cap
$1.9B
P/E
0.0×
Fwd P/E
−7.1×
Dividend yield
—
F-score
5/9
Altman Z
1.10
Beneish M
−3.47
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

3 5 3 3
ROE
(45.67%) (26.29%) (30.12%) (16.18%)
ROA
(26.61%) (13.33%) (15.03%) (8.18%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(50.67%) (29.54%) (32.87%) (17.19%)
Average Days of Receivables
81.54 148.92 68.99 57.95
Free Cash Flow per Share
(0.05) 0.17 (2.00) (1.74)
Free Cash Flow
(3.39) 12.46 (148.35) (130.27)
Capital Expenditures
(2.27) (1.44) (3.35) (3.40)
Other line items
Cash ROIC
(0.47%) 1.63% (20.61%) (17.42%)
Accounts Receivable Turnover
5.03 1.42 5.39 6.65
Accounts Payable Turnover
10.52 10.24 9.57 11.69
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
31.30 36.91 38.29 33.72
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.01 0.01 0.01 0.05
Research and Development Expense of Revenue
70.48% 67.67% 67.13% 65.23%
Selling, General and Administrative Expense of Revenue
54.02% 53.30% 52.85% 50.87%
Share Based Compensation of Revenue
17.72% 16.80% 15.89% 14.93%
Operating CF/Net income
0.01 (0.13) 1.40 2.34
Depreciation/Fixed assets
0.31 0.31 0.29 0.30
Capex/Depreciation
(0.36) (0.24) (0.57) (0.58)
Revenue per Share
3.49 3.48 3.45 3.47
Operating CF per Share
(0.02) 0.19 (1.96) (1.70)
Capex per Share
(0.03) (0.02) (0.05) (0.05)
Capex to Sales
0.01 0.01 0.01 0.01

Fold the line items

Columns are period end dates